Press Releases Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 01:30:00 01/05/2024 am IST			5-day change	1st Jan Change
1.65 ^USD	+3.12%		+12.24%	-83.18%

22/04	JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight	MT
18/04	Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries	04:59pm	AQ
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	16/04	PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03	PR
PacBio Grants Equity Incentive Award to New Employee	23/03	PR
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	12/03	PR
PacBio to Present at Upcoming Investor Conferences	27/02	PR
Federal Circuit Affirms Claim Construction And How It Applies	21/02	AQ
Pacific Biosciences: Q4 Earnings Snapshot	16/02	AQ
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results	16/02	PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch	13/02	PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	05/02	PR
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024	26/01	PR
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions	15/01	PR
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively	08/01	PR
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference	28/12	PR
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors	11/12	PR
PacBio to Present at Upcoming Investor Conferences	10/11	PR
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible	01/11	PR
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications	31/23/31	PR
Pacific Biosciences: Q3 Earnings Snapshot	31/23/31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Press Releases

Filters